RecruitingPhase 3NCT04267848Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Sponsor: National Cancer Institute (NCI)Annapolis, MD · Baltimore, MD · +1147 more sites
RecruitingPhase 1 / Phase 2NCT07278479Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsSponsor: Molecular Partners AGGlen Burnie, MD · +5 more sites
RecruitingPhase 1NCT07020117A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsSponsor: Aktis Oncology, Inc.Glen Burnie, MD · +13 more sites
RecruitingPhase 1NCT05283330Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsSponsor: Orano Med Theranostics, SASGlen Burnie, MD · +6 more sites
RecruitingPhase 1NCT06800339A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung CancerSponsor: University of Maryland, BaltimoreBaltimore, MD · Bel Air, MD · +1 more sites